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Introduction
Cholangiocarcinoma (CCA) is highly prevalent in 
Asian countries, particularly in Thailand, China, Taiwan 
and Korea (Shin et al., 2010). The principal risk factor 
for CCA in this region is infection with the human liver 
flukes, Opisthorchis viverrini and Clonorchis sinensis, 
which are Group 1 carcinogens as classified by the World 
Health Organization (Sripa et al., 2007; 2012; Bouvard et 
al., 2009; IARC, 2012). Thailand has the highest incidence 
of CCA worldwide due to its robust association with 
opisthorchiasis (Sripa and Pairojkul, 2008; Shin et al., 
2010). However, several other risk factors for this cancer 
have been documented including primary sclerosing 
cholangitis (see Rizvi and Gores, 2013), inflammatory 
bowel disease (Huai et al., 2014), metabolic syndromes 
(Wu et al., 2012), hepatitis virus (Matsumoto et al., 2014) 
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Abstract
 There has been a strong, positive correlation between opisthorchiasis-associated cholangiocarcinoma and 
infection with Helicobacter. Here a rodent model of human infection with Opisthorchis viverrini was utilized to 
further investigate relationships of apparent co-infections with O. viverrini and H. pylori. A total of 150 hamsters 
were assigned to five groups: i) Control hamsters not infected with O. viverrini; ii) O. viverrini-infected hamsters; 
iii) non-O. viverrini infected hamsters treated with antibiotics (ABx); iv) O. viverrini-infected hamsters treated 
with ABx; and v) O. viverrini-infected hamsters treated both with ABx and praziquantel (PZQ). Stomach, 
gallbladder, liver, colonic tissue, colorectal feces and O. viverrini worms were collected and the presence of 
species of Helicobacter determined by PCR-based approaches. In addition, O. viverrini worms were cultured in 
vitro with and without ABx for four weeks, after which the presence of Helicobacter spp. was determined. In situ 
localization of H. pylori and Helicobacter-like species was performed using a combination of histochemistry and 
immunohistochemistry. The prevalence of H. pylori infection in O. viverrini-infected hamsters was significantly 
higher than that of O. viverrini-uninfected hamsters (p≤0.001). Interestingly, O. viverrini-infected hamsters treated 
with ABx and PZQ (to remove the flukes) had a significantly lower frequency of H. pylori than either O. viverrini-
infected hamsters treated only with ABx or O. viverrini-infected hamsters, respectively (p≤0.001). Quantitative 
RT-PCR strongly confirmed the correlation between intensity H. pylori infection and the presence of liver fluke 
infection. In vitro, H. pylori could be detected in the O. viverrini worms cultured with ABx over four weeks. In 
situ localization revealed H. pylori and other Helicobacter-like bacteria in worm gut. The findings indicate that 
the liver fluke O. viverrini in the biliary tree of the hamsters harbors H. pylori and Helicobacter-like bacteria. 
Accordingly, the association between O. viverrini and H. pylori may be an obligatory mutualism. 
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and infection with Helicobacter spp. (Zhou et al., 2013). 
The latter has attracted increasing research interest in 
recent years (Mateos-Munoz et al., 2013; Murphy et al., 
2014).
Helicobacter pylori infection was the first bacterial 
infection known to be a causative factor of gastrointestinal 
diseases including gastric adenocarcinoma (Bouvard et 
al., 2009). Its virulence factors such as cagA and vacA are 
involved in the pathogenesis of the diseases (Cid et al., 
2013; Hatakeyama, 2014). Other Helicobacter species, 
specifically H. hepaticus and H. bilis also are implicated 
in hepatobiliary disease (Zhou et al., 2013; Mateos-
Muñoz et al., 2013; Murphy et al., 2014). We observed 
an association between H. pylori and hepatolithiasis or 
CCA in people in Northeast Thailand, a region endemic 
for opisthorchiasis (Boonyanugomol et al., 2012b; 
2012c). Molecular mechanisms integral to H. pylori 
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induced hepatobiliary diseases have also been reported 
(Boonyanugomol et al. 2011; 2012a). However, the 
underlying mechanisms by which species of Helicobacter 
associate with opisthorchiasis remain unclear. Here we 
investigated the prospective inter-relationship between 
infections with Helicobacter spp. and liver flukes in a 
rodent model of this foodborne liver fluke infection.
Materials and Methods
Animals 
Female Syrian hamsters, Mesocricetus auratus, about 
8 weeks of age were housed in conventional conditions, 
fed a commercial diet and given water ad libitum. Rodent 
husbandry conformed to the ethical guidelines of the 
Animal Laboratory Center, Faculty of Medicine, Khon 
Kaen University; these studies were approved by the 
Animal Ethics Committee of Khon Kaen University; 
approval number AEKKU # 100/2555. Laboratory 
infection of hamsters with O. viverrini was accomplished 
by oral administration of 50 metacercariae, as described 
(Lvova et al., 2012). Infected hamsters were maintained up 
to three months after the infection; control, non-infected 
hamsters were housed in identical conditions.
Experimental design
The hamsters (n=150) were assigned to five groups of 
30 rodents each (Table 1): group 1 - uninfected controls 
(n=30); group 2 - hamsters treated with antibiotics (ABx) 
(clarithromycin 7.5 mg/kg BID+ metronidazole 20mg/
kg BID + amoxicillin 20 mg/kg BID), omeprazole 0.7 
mg/kg BID and sucralfate 300 mg/kg) twice a day for 
14 days, as described (Khoshnegah et al., 2011); group 
3 - O. viverrini infected hamsters; group 4 - O. viverrini-
infected hamsters treated with ABx for 14 days; group 
5 - O. viverrini-infected hamsters treated with ABx 
for 14 days and then treated with praziquantel (PZQ) 
(Biltricide, Bayer, Pittsburgh, PA) suspended in 2% 
Cremophor EI (Sigma, St. Louis, MO) at 400mg/kg body 
weight twice, with an interval of two weeks between 
treatments aiming to eradicate the parasites. Hamsters 
were euthanized, after which colorectal feces, stomach, 
gallbladder, liver and worms were collected from each 
group for DNA extraction. Some worms were cultured for 
up to four weeks in RPMI 1640 medium supplemented 
with penicillin and streptomycin. Samples of livers from 
selected hamsters were fixed in 10% buffered formalin for 
histochemistry and immunohistochemistry.
DNA extraction 
One gram of stool sample was used for DNA extraction 
using a QIAamp® DNA Stool Mini Kit (Qiagen, Germany). 
The worms, liver, stomach, gallbladder and colon were 
incubated with lysis buffer (10 mM Tris-HCl pH 8.5, 10 
mM EDTA, 100 mM NaCl, 0.5% SDS), homogenized 
with tissue grinder, and digested with proteinase K at 
55°C overnight. Thereafter, DNAs were recovered using 
precipitation with ethanol. 
Molecular detection of Helicobacter species by PCR
Fifty ng DNA from each stool was used in the PCR 
assay. The reaction mixture consisted of 1x GoTaq® 
Colorless Master Mix (Promega, USA) containing 0.2 mM 
dNTP, 1.5 mM MgCl2, primers at 0.2 mM and 1.25 U of 
Taq DNA polymerase. Primer sequences for the detection 
of Helicobacter spp. (16srRNA), H. pylori (ureA), H. bilis, 
H. hepaticus are provided in Table 2. PCR was performed 
in a GeneAmp® PCR system 9700 (Applied Biosystems, 
Life Technologies) thermocycler. Amplified products 
were sized by electrophoresis through 1.0% agarose, 
stained with ethidium bromide and visualized under a 
UV illuminator. 
Table 1. Treatment Groups of Hamsters Infected with 
the Liver Fluke Opisthorchis viverrini
Group Number of Infection with ABx PZQ
 hamsters O. viverrini  
1 30 - - -
2 30 + - -
3 30 - + -
4 30 + + -
5 30 + + +
*ABx, antibiotics; PZQ, praziquantel 
Table 2. Primer Sequences and PCR Conditions for the Detection of Species of Helicobacter
Genes Primer sequences       PCR conditions Product size (bp)    References
 OF-ATTAGTGGCGCACGGGTGAGTAA 94oC 30 sec, 55oC 30 sec, 1,300 Pellicano et al. 
16Sr RNA OR-TTTAGCATCCCGACTTAAGGC 72oC 1.5 min (35 cycles)  (2004)
(nested PCR)  94oC 30 sec, 60oC 30 sec,  
 IF-GAACCTTACCTAGGCTTGACATTG 72oC 30 sec (35 cycle 480 
 IR-GGTGAGTACAAGACCCGGGAA   
ureA OF-GCTAATGGTAAATTAGTTCCTGG 94oC 30 sec, 62oC 30 sec, 411 Pellicano et al.
(nested PCR) OR-CTCCTTAATTGTTTTTACATAGTTG 72oC 30 sec (40 cycles)  (2004)
  94oC 30 sec, 59oC 30 sec,  
 IF-AGTTCCTGGTGAGTTGTTCTTAA 72oC 30 sec (40 cycles) 350 
 IR-AACCACGCTCTTTAGCTCTGTC   
H. bilis OF-CTATGACGGGTATCCGGC 98oC 10 sec, 55oC 30 sec, 718 Hamada et al. 
 OR-CTCACGACACGAGCTGAC 72oC 1 minute (35 cycles)  (2009)
 IF- CAGAACTGCATTTGAAACTAC 98oC 15 sec, 57oC 30 sec, 418 
 IR-AAGCTCTGGCAAGCCAGC 72oC 30 sec (35 cycles)  
H. hepaticus  OF-CTATGACGGGTATCCGGC 98oC 10 sec, 55oC 30 sec, 718 Hamada et al.
 OR-CTCACGACACGAGCTGAC 72oC 1 minute (35 cycles)  (2009)
 IF -GAAACTGTTACTCTG 98oC 15 sec, 56oC 30 sec, 405 
 IR-TCAAGCTCCCCGAAGGG 72oC 30 sec (35 cycles)  
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Quantitative real time PCR
H. pylori was quantified by real time PCR in all 
stool DNA samples and worms from the five groups of 
hamsters, as described (McDaniels et al., 2005; Linke et 
al., 2010), with minor modifications. The H. pylori ureA 
gene subunit ureA was targeted for real-time PCR, using 
primers HpyF1: GGGTATTGAAGCGATGTTTCCT 
and HpyR1: GCTTTTTTGC-CTTCGTTGATAGT. The 
reaction mixture included 10 µl SYBR Green Master Mix 
(Thermo Scientific, USA), 1.0 µl template DNA; 0.5 µl 
of each primer (0.625 µM) and 9 µl nuclease-free water. 
Thermocycling conditions using Roche’s Light Cycler 
1.5 were: 9 min initial denaturation at 95°C, 40 cycles 
of 15 s at 95°C and 60 s at 60°C for the annealing and 
elongation steps. To quantify number of bacterial cells in 
samples, a standard curve derived was established using 
10-fold serial dilutions of H. pylori DNA from 108 cells/
ml. Cell numbers of H. pylori cell count in one gram of 
colorectal feces was ascertained by the standard curve at 
crossing point and log concentration, as described (Linke 
et al., 2010). The cell concentration/amount of DNA 
was calculated to obtain the same initial amount for all 
templates. Escherichia coli was used as negative control. 
In situ localization of H. pylori in O. viverrini flukes
Formalin-fixed and paraffin-embedded tissue sections 
of O. viverrini infected hamster livers were histochemically 
stained using the Warthin-Starry method (Hartman and 
Owens, 2012). Briefly, sections were deparaffinized, 
hydrated to water, rinsed in acidic distilled water pH 
3.8-4.4, and stained with 1% silver nitrate solution 
for 45 seconds in a microwave oven. After cooling to 
room temperature, the slides were immersed in 0.15% 
hydroquinone, 5% gelatin, 2% silver nitrate (reducing 
solution) for one minute, rinsed thoroughly in tap water, 
then dehydrated, cleared and mounted.
Specific localization of H. pylori was also undertaken 
using an immunohistochemistry approach. In brief, 
hydrated thin tissue sections were subjected to antigen 
retrieval in 0.01 mol/l citrate buffer using a high 
temperature pressure cooker; endogenous peroxidase 
activity was blocked with 3% hydrogen peroxide in 
methanol. Non-specific staining was minimized by 
incubation in 5% normal horse serum in PBS. Sections 
were probed with anti H. pylori rabbit polyclonal antibody 
(Dako) overnight (primary antibody). After washing with 
PBS, sections were incubated in biotinylated goat anti-
rabbit IgG-HRP (Dako) for 60 min (secondary antibody), 
washed and developed with 3,3’- diaminobenzidine (DAB) 
(Sigma). Subsequently, sections were counterstained in 
Mayer’s heamatoxylin, cleared, and mounted. Paraffin-
embedded gastric tissue from H. pylori-infected patient 
was used as positive control. Negative control sections 
were probed only with secondary antibody.
Statistical analyses 
Chi-square (X2) or Fisher’s exact test was used to 
compare the categorical data among treatment groups. 
One-way ANOVA (Post Hoc test) was used to compare the 
means of total cell counts per gram feces. p values≤0.05 
were considered to be statistically significant. 
Results 
Prevalence of Helicobacter in hamster feces 
Figure 1 presents the prevalence of infection with 
species of Helicobacter as determined by fecal PCRs 
targeting the 16S rRNA, ureA, H. bilis, and H. hepaticus-
specific genes in O. viverrini-infected hamster with and 
without treatments and controls. Baseline prevalence 
of species of Helicobacter was significantly higher in 
hamsters with O. viverrini infection (90%) than in non-O. 
viverrini infected hamsters (43.3%) (p≤0.001). Similarly, 
the prevalence of species of Helicobacter in the O. 
viverrini infected group was significantly higher than both 
the O. viverrini-infected group treated with ABx (46.7%) 
and the O. viverrini-infected group treated with ABx and 
PZQ (30%) (p≤0.05). Notably, the prevalence of H. pylori 
infection (ureA gene positive) was significantly higher in 
hamsters without O. viverrini infection (33.3%) than that 
in non-O. viverrini infected hamsters treated with ABx 
(16.7%) (p≤0.001). 
Moreover, the prevalence of H. pylori in hamster 
infected with O. viverrini (73.3%) was significantly higher 
than in hamsters infected with O. viverrini and treated 
with ABx (36.7%) and in those treated with both ABx and 
PZQ (16.7%) (p≤0.001). Likewise, the prevalence of H. 
bilis but not H. hepaticus infection was higher in the O. 
viverrini infected hamsters (40%) than the non-O. viverrini 
infected rodents (26.7%) (p≤0.001). In addition, H. bilis 
infection was more prevalent in hamsters with O. viverrini 
infection (26.7%) than in hamsters with O. viverrini 
treated with ABx (13.3%) and the O. viverrini infected 
group treated with ABx and PZQ (13.3%) (p≤0.05). Last, 
and notable, the prevalence of H. pylori and H. bilis was 
lower in hamsters infected with O. viverrini and treated 
with ABx and PZQ than in O. viverrini-infected hamsters 
treated only with ABx, and was similar to that in the 
non-O. viverrini infected hamsters.
Prevalence of Helicobacter pylori in hamster organs
The prevalence of H. pylori in diverse hamster organs-
stomach, liver, colon, gallbladder including feces from 
Figure 1. Prevalence of Helicobacter spp. Infection 
in feces from 5 groups of hamsters. X-axis represents PCR 
positivity (%) of Helicobacter 16SrRNA, UreA, H. bilis, and 
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colon, varied among the treatment groups (Figure 2). H. 
pylori was more common (>70%) in colon and feces of O. 
viverrini-infected compared to <40% in control hamsters 
not infected with O. viverrini (p ≤ 0.001). After treatment 
with ABx, the prevalence of H. pylori in both colon and 
colorectal feces declined significantly. The prevalence of 
H. pylori was significantly lower in O. viverrini-infected 
hamsters treated with ABx and PZQ - 16.7% vs 66.7% 
and 16.6% vs. 73.9% for the colon tissue and feces, 
respectively (p≤0.001), levels about half those from the 
ABx treated hamsters. 
For the liver and gallbladder, in like fashion, 
significantly higher prevalence of H. pylori was seen 
in hamsters infected with O. viverrini compared to 
non-infected controls (16.6% vs 6.7% and 18.0% vs 
6.7%, respectively). Treatments with ABx and PZQ of 
O. viverrini-infected hamsters significantly reduced the 
prevalence of H. pylori to less than half of their ABx 
baselines in both the liver and gallbladder (6.7% vs. 
3.3% and 10.0% vs 3.3%, respectively). Similar to other 
organs, infection prevalence of H. pylori in the stomach 
was significantly higher in in O. viverrini infected (26.7%) 
compared to uninfected hamsters (18.0%) (p≤0.05). 
However, the prevalence of H. pylori in O. viverrini-
infected hamsters treated with ABx and PZQ (13.3%) was 
similar to those treated with ABx alone (13.3%), unlike 
those organs/ tissues reported above. In overview, the 
prevalence of H. pylori in organs of the ABx and PZQ 
treated hamsters declined to about their ABx-treated 
baselines.
Quantification H. pylori by quantitative real-time PCR 
(qPCR)
Levels of H. pylori (H. pylori cell counts) in the five 
groups of hamsters, as established from the qRT-PCR 
standard curve, are presented in Figure 3. Significantly 
divergent intensities of infection with H. pylori were 
Figure 3. Quantification of Helicobacter pylori in 
Colorectal Feces of Hamsters Using Quantitative RT-
PCR. Total bacterial cell counts among the following 5 
groups of hamsters are compared; 1. Control (Group 1), 
2. Control+ ABx (Group 2), 3. Infected hamster (Group 
3), 4. Infected hamster + ABx (Group 4), and 5. Infected 
hamster + ABx+ PZQ (Group 5). *Significant difference 
among groups (p≤0.001)
Figure 4. Quantification of Helicobacter pylori in O. 
viverrini from Infected Hamsters (Group 2) and O. 
viverrini from Infected Hamsters Treated with ABx 
(Groupp 3). Data are representative of bacterial counts 
from 5 worms/hamster recovered from each group
Figure 5. Representative PCR Products Amplified by 
using Helicobacter pylori Specific Primer (Product 
Size=350 bp) from O. viverrini Worms (Recovered 
from Group 2) Cultured with Antibiotics upto 4 
Weeks, Excretory-secretory (ES) Products, Fresh 
Worms and Ov metacercariae. M=Maker, N=Negative 
control, Lane 1=Positive control (H. pylori), Lane 2=Fresh 
Ov, Lane 3=Ov cultured 1 week, Lane 4=Ov cultured 2 
weeks, Lane5=Ov cultured 3 weeks Lane6=Ov cultured 
4 weeks, Lane7=ES products and Lane 8=Metacercariae, 
respectively.  Data are reprehensive of PCR products 
amplified from DNA extracted from10 worms per 
duration or DNA from 500 O. viverrini metacercariae. 
Ov=Opisthorchis viverrini






Figure 2. Prevalence of Helicobacter pylori Infection in 
Various Hamster Organs by PCR. Data (%) for H. pylori 
#(p≤0.001) and *(p≤0.05)
* # # 
# # # # 
# 
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evident: O. viverrini-infected hamsters, 695,712±270,962 
cells (mean ±SD/five worms); O. viverrini infected 
hamsters treated with ABx, 297,033±167,158; O. 
viverrini infected hamsters treated with ABX and PZQ, 
86,763±86,585; uninfected hamsters, 52,105± 40,004; 
and uninfected hamsters treated with ABx, 34,497±18,360 
(p≤0.001). Overall, H. pylori infection intensity in O. 
viverrini infected hamsters was significantly greater 
than that of uninfected hamsters (p≤0.001). Of note, 
O. viverrini infected hamsters treated with ABx and 
PZQ showed significant reduction of H. pylori infection 
intensity (p≤0.001), similar to levels detected in the 
non-O. viverrini-infected hamsters treated or not treated 
with ABx.
The quantification of H. pylori in O. viverrini worms
The H. pylori infection intensity in O. viverrini 
recovered from hamsters (mean=13,806±6,162 cells/5 
worms) was significantly greater than that in O. viverrini 
from infected hamsters treated with ABx (9,951±3,220) 
(Figure 4).
Detection of H. pylori in cultured O. viverrini worms
To investigate the presence of H. pylori in long-
term culture with ABx, we did examine by PCR up to 
4 weeks culture as well as in fresh worms, ES products 
and metacercariae. The results showed that H. pylori 
could be observed in fresh recovered adults, all cultured 
worms, and ES products but not in the metacercariae of 
O. viverrini (Figure 5). 
In situ localization of H. pylori in O. viverrini
To directly investigate the existence/presence of H. 
pylori in the O. viverrini flukes, in situ localization using 
the Warthin-Starry technique and immunohistochemistry 
was undertaken. Warthin-Starry staining revealed dark 
brown curved rod-like structures that clearly resembled 
H. pylori within the lumen of the gut of the flukes (Figure 
6A). In like fashion, immunohistochemical staining with 
antibody specific for H. pylori showed strong, positive 
signals for the bacteria in the lumen of the gut of the 
flukes (Figure 6B).
Discussion
Cholangiocarcinoma is highly prevalent in Asian 
countries; particularly in Thailand (Shin et al., 2010) 
and, besides dietary carcinogens, the main risk factor 
is infection with the human liver flukes, O. viverrini 
and Clonorchis sinensis (Sripa et al., 2007; Sripa and 
Pairojkul, 2008; Petney et al., 2013; Sithithaworn et al., 
2014). Other risk factors associated with the infection such 
as microbiota in the biliary system may also be involved 
(Plieskatt et al., 2013). We recently found a significant 
association between H. pylori or mixed H. pylori and H. 
bilis but not H. hepaticus infection and CCA in patients 
from Northeast Thailand, a region highly endemic for 
opisthorchiasis (Boonyanugomol et al., 2012b; 2012c). 
However, which species of Helicobacter associate with 
opisthorchiasis, and why, remain unclear. We show here, 
for the first time in a rodent model a human opisthorchiasis, 
significantly higher prevalence of co-infection with H. 
pylori and H. bilis but not H. hepaticus in O. viverrini-
infected and uninfected hamsters. Interestingly, clearance 
of the liver fluke infection following treatment with PZQ 
significantly reduced the prevalence and intensity of H. 
pylori in O. viverrini-infected hamsters suggested a strong 
inter-relationship between the two pathogens. In addition, 
in situ localization revealed H. pylori in the gut of the 
worm and the presence of of H. pylori in worms cultured 
with lengthy periods in antibiotics supports that adult O. 
viverrini may act as a reservoir for H. pylori.
Species of Helicobacter including H. pylori, H. 
hepaticus and H. bilis have been described from several 
other mammals as well as from people (Fox et al., 1995; 
Pellicano et al., 2008; Goldman et al., 2010). Fox et 
al. (2009) reported hamsters naturally infected with H. 
bilis and that aged animals showed chronic hepatitis, 
hepatic dysplasia, fibrosis, and biliary hyperplasia. 
During other liver fluke infections, H. bilis-like bacteria 
has been identified in the intrahepatic bile ducts of 
rats experimentally infected with Fasciola hepatica 
(Foster, 1984). Our study reported a significant higher 
prevalence of H. pylori and H. bilis but not H. hepaticus 
in the colon feces of O. viverrini infected hamsters 
Figure 6. Identification of Helicobacter pylori in the O. viverrini Gut. (A) Cluster of H. pylori-like (short arrow) stained 
with the Warthin-Starry method shown as dark brown curved rod-like bacteria in the lumen. (B) Specific detection of H. pylori with 
anti-H. pylori antibody immunostained as a dark brown color (short arrow). Original magnification, x400
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compared to uninfected hamsters both before and after 
ABx treatment. We further investigated the source of 
the higher fecal infection by examining the prevalence 
of H. pylori in the stomach, liver, gallbladder, and colon 
mucosa. Helicobacter spp. have been observed previously 
in these sites (Fox et al., 1995). The findings presented 
here demonstrated infection of liver and gallbladder with 
H. pylori, and indicated that the H. pylori in these organs 
originated from the liver fluke in the bile ducts rather than 
from microbiome of the hamster stomach. The findings 
indicated that infection with O. viverrini influenced the 
higher positivity and intensity in the feces since levels 
of H. pylori significantly declined following treatments 
with ABx and PZQ (Figures 2 and Figure 3). The source 
of Helicobacter infection of the liver and biliary system 
may be ascending infection through the small intestine 
(Pellicano et al., 2008). Partial bile duct obstruction 
by the flukes as well as host inflammatory responses 
cause bile stasis and facilitate ascending infection and 
cholangitis (Carpenter, 1998; Sripa, 2003). We recently 
reported higher number of bacterial species in O. viverrini 
infected hamster bile and also colorectal feces (Plieskatt 
et al., 2013). Although Helicobacter is bile-sensitive, the 
mechanism by which colonization by this microbe of the 
biliary system is accomplished is uncertain. It has been 
suggested that the ‘acidification’ of bile through reflux 
into the low pH of the stomach precipitates inhibitory bile 
acids, thereby allowing colonization by H. pylori (Hynes et 
al., 2003; Shao et al., 2008). In case of opisthorchiasis, the 
infection by the flukes can disturb bile acid composition 
(Wongpaitoon et al., 1988; Wonkchalee et al., 2012) that 
may reduce alkalinity of the bile, leading to damage to 
biliary epithelia and inflammation (Strazzabosco et al. 
2000). All these phenomena may facilitate conditions 
that favor colonization by Helicobacter during concurrent 
infection with liver flukes.
Whether the presence of H. pylori in the biliary system 
during opisthorchiasis occurs only in the bile and biliary 
mucosa or also within the fluke had until now remained 
unresolved. Here we demonstrated in situ localization of 
H. pylori histochemically and immunohistochemically 
in the gut or gastrodermal of the fluke. Accidental 
contamination during specimen preparation cannot 
account for these new findings since H. pylori was 
qualitatively and quantitatively detected in the thoroughly 
washed worms and cultured in the presence of ABx for 
more than a month. However, the origin of infection of 
the liver fluke with Helicobacter spp. is unclear. The fluke 
likely ingests bile contents and biliary epithelium for 
nutrition (Sripa, 2003; Sripa et al., 2007), and H. pylori is 
likely ingested in the bile by the fluke. We postulate that H. 
pylori can colonize and propagate in the gut epithelium of 
O. viverrini and, in turn, continue to be released back into 
bile with the excretions and secretions (ES) of the flukes. 
DNA from H. pylori can be detected by PCR in the ES 
products of the cultured worms (Figure 5). The epithelia 
of the gut of O. viverrini may provide conditions favorable 
to Helicobacter i.e. acidic to neutral pH, mucus as well 
as specific adhesion molecules (Sachs et al, 2011; Dunne 
et al., 2014). Together, these new findings suggest that O. 
viverrini within the mammalian hepatobiliary system may 
be a reservoir of H. pylori.
The elevated prevalence of Helicobacter spp. in O. 
viverrini-infected hamsters raises the question of whether 
infection with Helicobacter contributes to pathogenesis 
of hepatobiliary diseases as well as CCA. Hepatobiliary 
diseases caused by species of Helicobacter in naturally 
infected hamsters (Fox et al., 2009; Boonyanugomol 
et al. 2012b; 2012c) are similar to those of O. viverrini 
(Lvova et al., 2012; Mairiang et al., 2012). Indeed, the 
chronic lesions ascribed to liver fluke infection in both 
hamsters and humans, i.e., cholangitis, biliary hyperplasia 
and metaplasia, and periductal fibrosis or even CCA may 
be due, in part, to Helicobacter-associated hepatobiliary 
disease. H. pylori and H. bilis DNA has been isolated 
from liver tissue of humans with CCA and cholecystitis/
cholelithiasis from Thai patients living in regions endemic 
for opisthorchiasis (Boonyanugomol et al. 2012b; 2012c). 
Moreover, serological assays indicate active infection with 
H. pylori and H. bilis in Thais at high risk for CCA (Pisani 
et al., 2008). H. bilis was also associated with biliary 
cancers in two high-risk populations in Japan and Thailand 
(Matsukura et al., 2002). The strong association between 
liver fluke and H. pylori or H. bilis infection reported in 
this study supports a role of these Helicobacter species in 
the hepatobiliary diseases known during opisthorchiasis.
In conclusion, this study in a well-controlled hamster 
model of infection revealed a significant relationship 
between O. viverrini and Helicobacter spp., specifically H. 
pylori and H. bilis. The in situ localization of H. pylori in 
the gut of the fluke supports the hypothesis that O. viverrini 
may be a reservoir of this carcinogenic bacterium. The 
co-infection may orchestrate in the pathogenesis of liver 
fluke-induced hepatobiliary diseases including CCA. 
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